Who owns BriaCell Therapeutics Corp.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BCTXZ from SEC Form 13F filings across 5 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 5 institutions disclosed 631,698 shares of BriaCell Therapeutics Corp. worth $55,689 — about 8.7% of shares outstanding; the largest disclosed holder is HEIGHTS CAPITAL MANAGEMENT, INC. Source: SEC Form 13F filings, parsed by EvidInvest.
5
13F holders
$55,689
value, 2026 filers
8.7%
of shares outstanding (631,698 sh)
3
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BCTXZ's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | HEIGHTS CAPITAL MANAGEMENT, INC | 313,379 | $31,338 | 0.0% | 4.3% | -42.0% |
| 2 | SABBY MANAGEMENT, LLC | 120,802 | $11,464 | 0.0% | 1.7% | -41.6% |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 114,522 | $11,452 | 0.0% | 1.6% | new |
| 4 | HRT FINANCIAL LPNEW | 67,935 | $6 | 0.0% | 0.9% | new |
| 5 | TWO SIGMA SECURITIES, LLCNEW | 15,060 | $1,429 | 0.0% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.